| scholarly article | Q13442814 |
| P50 | author | Xing-Mei Zhang | Q73642410 |
| P2093 | author name string | Yue Chen | |
| Fang Wang | |||
| Xiaowen Li | |||
| Li Peng | |||
| Yanling Liang | |||
| Yusheng Shi | |||
| Zhiman Liang | |||
| Zhewen Kou | |||
| Guangwei Shi | |||
| P2860 | cites work | Cell signaling by receptor tyrosine kinases | Q24598357 |
| Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date | Q26822717 | ||
| Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase | Q27860794 | ||
| In vitro selection of RNA molecules that bind specific ligands | Q27861109 | ||
| Aptamers in analytics. | Q28075607 | ||
| MDC1 is required for the intra-S-phase DNA damage checkpoint | Q28212500 | ||
| The somatic genomic landscape of glioblastoma | Q28300185 | ||
| A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death | Q28740749 | ||
| Integration of EGFR inhibitors with radiochemotherapy | Q79227019 | ||
| 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression | Q28829149 | ||
| A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer | Q33518347 | ||
| Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts | Q33893647 | ||
| Nucleic acid aptamers: clinical applications and promising new horizons | Q34028112 | ||
| Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma | Q34655394 | ||
| Cell-SELEX aptamer for highly specific radionuclide molecular imaging of glioblastoma in vivo. | Q35112737 | ||
| Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells | Q35804765 | ||
| Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors | Q35967385 | ||
| Systemic Administration and Targeted Radiosensitization via Chemically Synthetic Aptamer-siRNA Chimeras in Human Tumor Xenografts | Q36359552 | ||
| Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma. | Q36512160 | ||
| Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest | Q36586535 | ||
| EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma | Q37223890 | ||
| MET inhibition overcomes radiation resistance of glioblastoma stem-like cells | Q37458626 | ||
| Oncogenic EGFR signaling networks in glioma | Q37593841 | ||
| Application of locked nucleic acids to improve aptamer in vivo stability and targeting function | Q37619467 | ||
| Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma | Q37626600 | ||
| Targeting DNA repair mechanisms in cancer | Q38056316 | ||
| Glioblastoma: from molecular pathology to targeted treatment | Q38128382 | ||
| ATM and ATR as therapeutic targets in cancer | Q38289832 | ||
| Aptamers as targeted therapeutics: current potential and challenges | Q38290290 | ||
| Mitochondrial KATP Channels Control Glioma Radioresistance by Regulating ROS-Induced ERK Activation | Q38953888 | ||
| Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells | Q39009280 | ||
| Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384. | Q39012877 | ||
| Aptamers as Therapeutics | Q39070782 | ||
| Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production | Q39084413 | ||
| EGFR cooperates with glucose transporter SGLT1 to enable chromatin remodeling in response to ionizing radiation | Q39163503 | ||
| Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer | Q39564618 | ||
| Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial | Q40251565 | ||
| Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells | Q40323053 | ||
| Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity | Q40505726 | ||
| Suppression of invasion in human U87 glioma cells by adenovirus-mediated co-transfer of TIMP-2 and PTEN gene | Q45877890 | ||
| CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR. | Q48559378 | ||
| Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth factor receptor-Akt-DNA-PK signaling, accompanied by inhibition of DNA double-strand break repair | Q48560121 | ||
| EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients | Q49861198 | ||
| EGFRvIII-mediated radioresistance through a strong cytoprotective response | Q50335608 | ||
| microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. | Q54364560 | ||
| The comet assay: a method to measure DNA damage in individual cells | Q64388028 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 438-449 | |
| P577 | publication date | 2018-01-08 | |
| P1433 | published in | Molecular Therapy. Nucleic acids | Q27724110 |
| P1476 | title | Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells | |
| P478 | volume | 10 |
| Q92871476 | Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells |
| Q90409700 | Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma |
| Q64099030 | Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein Receptor |
| Q58562119 | EGFR confers radioresistance in human oropharyngeal carcinoma by activating endoplasmic reticulum stress signaling PERK-eIF2α-GRP94 and IRE1α-XBP1-GRP78 |
| Q89968185 | Post-SELEX Optimization and Characterization of a Prostate Cancer Cell-Specific Aptamer for Diagnosis |
Search more.